Experts doubt India’s timeline for COVID-19 vaccine
Although regulators globally have been fast-tracking trials on medicines and vaccines to treat COVID-19, the timeline envisaged in…
Author
Regeneron, Sanofi arthritis drug fails COVID-19 study
Previous trial results had shown that the drug did not help patients with less severe COVID-19, the disease caused by the novel…
US FDA approves GSK’s HIV drug for patients with limited options
The oral treatment from the company’s HIV unit, ViiV Healthcare, has been approved for adults whose HIV infection could not be…
COVID-19 vaccines to enter late-stage trial by end of July: US’s top infectious diseases expert
The news comes as Moderna, which is at the forefront of the country’s vaccine development efforts, reiterated earlier in the day…
Brazil to test Sinovac’s potential vaccine against COVID-19 in six states
The agreement with Sinovac includes not only trials but also the transference of technology to produce the coronavirus vaccine…
Novartis pays $729 million to settle US kickback charges
The Swiss drugmaker will pay $678 million to resolve claims it organized tens of thousands of sham educational events where it…
US FDA releases guidance for approval of COVID-19 vaccines
Over 100 vaccines are being tested globally against the virus
World takes stock of COVID-19 drug remdesivir after US snaps up supplies
The pharmaceutical company’s move stirred the global debate about equitable access to drugs and brought concerns about…
Inovio’s COVID-19 vaccine candidate shows promise in small early-stage trial
The vaccine induced immune responses in 34 of the 36 healthy volunteers aged 18 to 50 years, Inovio said
Scottish firm to trial T cells as possible COVID-19 treatment
TC BioPharm (TCB) said it would conduct the trial at the Edinburgh Royal Infirmary, using gamma-delta T cells in a technique it…